These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recent advances in chronic lymphocytic leukemia. Abbott BL Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159 [TBL] [Abstract][Full Text] [Related]
4. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia. Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492 [TBL] [Abstract][Full Text] [Related]
5. Advances in the diagnosis and treatment of chronic lymphocytic leukemia. Abbott BL Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221 [TBL] [Abstract][Full Text] [Related]
6. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia. Banerji V; Johnston JB; Seftel MD Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979 [TBL] [Abstract][Full Text] [Related]
8. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy. Giné E; Moreno C; Esteve J; Montserrat E Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838 [TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-). Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397 [TBL] [Abstract][Full Text] [Related]
14. Controversies in the front-line management of chronic lymphocytic leukemia. Nabhan C; Shanafelt TD; Kay NE Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives. García-Escobar I; Sepúlveda J; Castellano D; Cortés-Funes H Crit Rev Oncol Hematol; 2011 Oct; 80(1):100-13. PubMed ID: 21146422 [TBL] [Abstract][Full Text] [Related]
16. Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia. Brown JR; Kim HT; Li S; Stephans K; Fisher DC; Cutler C; Ho V; Lee SJ; Milford EL; Ritz J; Antin JH; Soiffer RJ; Gribben JG; Alyea EP Biol Blood Marrow Transplant; 2006 Oct; 12(10):1056-64. PubMed ID: 17084369 [TBL] [Abstract][Full Text] [Related]
17. Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia. Jaglowski SM; Byrd JC Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S132-8. PubMed ID: 22226097 [TBL] [Abstract][Full Text] [Related]
18. Recent progress in the management of chronic lymphocytic leukemia. Robak T Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis. Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173 [TBL] [Abstract][Full Text] [Related]